Scholars Central

Short communicationPublished 2020

Parkinson's disease

Authors: Ebru Kuyumcu Savan

Farmacologia y Toxicologia

Volume 10 · Issue 2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Parkinson's disease (PD) is a complex neurodegenerative age-related disease associated with loss of dopaminergic cells and both motor and non-motor disorders. PD is the second most common neurodegenerative disease that affects above 85 years of age and affects 2% of the population over 60 years of age. PD is the brain's reward that causes typical motor symptoms such as tremor, bradykinesia, rigidity, contraction, as well as non-motor symptoms such as executive dysfunction, mood and sleep disturbance, with constant loss of dopaminergic neurons in the substantia nigra (black substance) of the midbrain. It is defined as a disease caused by dopamine deficiency, a neurotransmitter that helps control learning and emotional centers [1-4].

Keywords

Subjects

Toxicology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Farmacologia y Toxicologia.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalFarmacologia y Toxicologia
  • SubjectToxicology
  • BylineArticles whose byline prints “Ebru Kuyumcu Savan”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels